Tarsus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2018
Market Capitalization	1,877	2,117	670	391	465	840	Upgrade
Market Cap Growth	215.74%	215.74%	71.44%	-15.95%	-44.60%	-	Upgrade
Enterprise Value	1,658	1,873	455	185	283	857	Upgrade
Last Close Price	48.92	55.37	20.25	14.66	22.50	41.33	Upgrade
PS Ratio	10.06	11.57	38.42	15.15	8.16	-	Upgrade
PB Ratio	8.36	9.43	3.40	2.03	2.79	5.06	Upgrade
P/TBV Ratio	9.79	9.79	3.47	2.03	2.79	5.06	Upgrade
P/FCF Ratio	-	-	-	147.13	-	Upgrade
P/OCF Ratio	-	-	-	124.13	-	Upgrade
EV/Sales Ratio	9.07	10.24	26.10	7.15	4.96	-	Upgrade
EV/FCF Ratio	-	-	-	89.41	-	Upgrade
Debt / Equity Ratio	0.32	0.32	0.15	0.10	0.01	0.01	Upgrade
Debt / FCF Ratio	-	-	-	-	0.38	-	Upgrade
Asset Turnover	0.57	0.57	0.07	0.13	0.33	-	Upgrade
Inventory Turnover	23.12	23.12	-	-	-	-	Upgrade
Quick Ratio	4.21	4.21	6.64	14.30	14.98	31.21	Upgrade
Current Ratio	4.43	4.43	6.93	14.61	15.33	31.68	Upgrade
Return on Equity (ROE)	-54.83%	-54.83%	-69.71%	-34.53%	-8.31%	-24.01%	Upgrade
Return on Assets (ROA)	-23.46%	-23.46%	-36.27%	-19.27%	-4.33%	-14.65%	Upgrade
Return on Capital (ROIC)	-28.75%	-28.75%	-40.65%	-20.58%	-4.54%	-15.04%	Upgrade
Earnings Yield	-6.15%	-5.46%	-20.27%	-15.88%	-2.97%	-3.19%	Upgrade
FCF Yield	-4.51%	-4.00%	-17.75%	-12.67%	0.68%	-2.57%	Upgrade
Buyback Yield / Dilution	-27.98%	-27.98%	-19.35%	-19.78%	-231.12%	-162.72%	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q